doi.org/10.1016/s0016-5085(20)33636-2

Tu1849 HISTOLOGIC REMISSION AND MUCOSAL HEALING IN A PHASE 2 STUDY OF MIRIKIZUMAB IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS

,

James B. Canavan

,

..., William J. Sandborn

Gastroenterology29.40

Volume: 158, Issue: 6, Pages: S - 1187

Published: May 1, 2020

Abstract

No abstract.

Paper Fields

Paper Details

Title

Tu1849 HISTOLOGIC REMISSION AND MUCOSAL HEALING IN A PHASE 2 STUDY OF MIRIKIZUMAB IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS

DOI

doi.org/10.1016/s0016-5085(20)33636-2

Published Date

May 1, 2020

Journal

Gastroenterology

Volume

158

Issue

6

Pages

S - 1187

Citation AnalysisPro

You’ll need to upgrade your plan to Pro

Looking to understand the true influence of a researcher’s work across journals & affiliations?

Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.

Notes

History